Concepedia

Tong Luo

TL

Statistics

Publications

4

Citations

428

H-Index

4

Active since

2014

Affiliations

University of California, Los Angeles(Current)

Novartis (Switzerland)

Tong Luo is an author at University of California, Los Angeles specializing in medicine, oncology, and breast cancer pharmacotherapy.

Publications per year

2014–2020

4

Publications

4

Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer

Neil A. O’Brien, Martina S.J. McDermott, Dylan Conklin et al. · Breast Cancer Research · 2020 · 156 citations · Full text

, , +16

Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT

Neil A. O’Brien, K McDonald, Tong Luo et al. · Clinical Cancer Research · 2014 · 117 citations

, , +17

Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer

Neil A. O’Brien, Dylan Conklin, Richard P. Beckmann et al. · Molecular Cancer Therapeutics · 2018 · 107 citations · Full text

, , +17

Abstract 4756: In vivo efficacy of combined targeting of CDK4/6, ER and PI3K signaling in ER+ breast cancer

Neil A. O’Brien, Emmanuelle di Tomaso, Raul Ayala et al. · Cancer Research · 2014 · 48 citations

, , +16

1–4 of 4